TG THERAPEUTICS INC earnings per share and revenue

NKB2 earnings per share for the last quarter are 0.02 EUR whereas the estimation was 0.03 EUR which accounts for -33.33% surprise. Company revenue for the same period amounts to 75.34 M EUR despite the estimated figure of 73.38 M EUR. Estimated earnings per share for the next quarter are 0.14 EUR, and revenue is expected to reach 105.59 M EUR. Also watch annual changes over time to get a bigger picture of NKB2 earnings per share and revenue dynamics.